Sera Prognostics | search
Click here to view Sera Prognostics news from 60+ newspapers.
Bookmark or Share- Sera Prognostics’ PreTRM® Test and Treat Strategy Benefits Demonstrated ...Sera’s precision medicine PreTRM test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with ...
- SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA METSera Prognostics today announced that the Data Safety Monitoring Board (DSMB) overseeing its pivotal PRIME study recommended stopping enrollment due to efficacy.
- Sera Prognostics | The Pregnancy CompanySera Prognostics aims to be a global leader in high-value women’s health diagnostics, delivering pivotal information to physicians to improve the health of pregnant women and newborns, and to simultaneously improve the health economics.
- Maternal and Fetal Healthcare Issues | Sera Prognostics Inc.Our vision is to become a global leader in high-value women’s health diagnostics. We’ll do this by taking a holistic approach to providing pivotal information to providers and patients, simultaneously enabling better health for moms and babies and improving the economics of healthcare delivery.
- PreTRM® Premature Birth Risk Blood Test from Sera PrognosticsThe PreTRM ® Test is the only clinically validated commercially available blood test that provides an early, individual risk assessment for spontaneous preterm birth in asymptomatic, singleton pregnancies. Learn more about how your practice can get started.
More
